Scilex Holding Company Interest Expense
Scilex Holding Company (SCLX) reported Interest Expense of $571.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-08-13
- Scilex Holding Company interest expense for the quarter ending 2024-06-30 was $571.00K, a 11320.00% increase year-over-year.
- Scilex Holding Company interest expense for the quarter ending 2024-03-31 was $531.00K.
- Scilex Holding Company interest expense for the quarter ending 2023-12-31 was $551.00K, a 45.34% decline year-over-year.
- Scilex Holding Company interest expense for the quarter ending 2023-09-30 was $513.00K, a 72.39% decline year-over-year.
- Scilex Holding Company interest expense for fiscal 2023 was $1.07M, a 88.88% decline from fiscal 2022.
- Scilex Holding Company interest expense for fiscal 2022 was $9.60M, a 18.36% decline from fiscal 2021.
- Scilex Holding Company interest expense for fiscal 2021 was $11.76M, a 10.31% decline from fiscal 2020.
- Scilex Holding Company interest expense for fiscal 2020 was $13.12M.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 10 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | $571.00K 10-Q · filed 2024-08-13 | $1.10M 10-Q · filed 2024-08-13 | $1.65M derived: sum of 3 quarters · filed 2024-08-13 | $2.17M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2024-03-31 | $531.00K 10-Q · filed 2024-05-13 | $1.08M derived: sum of 2 quarters · filed 2024-05-13 | $1.59M derived: sum of 3 quarters · filed 2024-05-13 | $1.60M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-12-31 | $551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $1.06M derived: sum of 2 quarters · filed 2024-03-12 | $1.07M derived: sum of 3 quarters · filed 2024-08-13 | $1.07M 10-K · filed 2024-03-12 | ||||
| 2023-09-30 | $513.00K 10-Q · filed 2023-11-14 | $518.00K derived: sum of 2 quarters · filed 2024-08-13 | $517.00K 10-Q · filed 2023-11-14 | $1.52M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-06-30 | $5.00K 10-Q · filed 2024-08-13 | $4.00K 10-Q · filed 2024-08-13 | $1.01M derived: sum of 3 quarters · filed 2024-08-13 | $2.87M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$1.00K 10-Q · filed 2024-05-13 | $1.01M derived: sum of 2 quarters · filed 2024-05-13 | $2.87M derived: sum of 3 quarters · filed 2024-05-13 | $2.87M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $2.87M derived: sum of 2 quarters · filed 2024-03-12 | $2.87M derived: sum of 3 quarters · filed 2024-03-12 | $9.60M 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | $1.86M 10-Q · filed 2023-11-14 | $1.16K 10-Q · filed 2022-11-04 | $1.87M derived: sum of 2 quarters · filed 2023-11-14 | $8.60M 10-Q · filed 2023-11-14 | $16.90K 10-Q · filed 2022-11-04 | $13.59M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2022-06-30 | $8.28K 10-Q · filed 2022-08-12 | $15.75K 10-Q · filed 2022-08-12 | $11.73M derived: sum of 3 quarters · filed 2024-03-12 | $11.73M derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2022-03-31 | $7.47K 10-Q · filed 2022-05-16 | $11.72M derived: sum of 2 quarters · filed 2024-03-12 | $11.72M derived: sum of 3 quarters · filed 2024-03-12 | $11.72M derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2021-12-31 | $11.71M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-03-12 | $11.71M derived: sum of 2 quarters · filed 2024-03-12 | $11.71M derived: sum of 3 quarters · filed 2024-03-12 | $11.76M 10-K · filed 2024-03-12 | $1.83K 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2021-12-08 | $0.00 derived: sum of 2 quarters · filed 2021-12-08 | $50.00K 10-Q/A · filed 2021-12-08 | |||||
| 2021-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2021-08-24 | $50.00K 10-Q/A · filed 2021-08-24 | ||||||
| 2021-03-31 | $50.00K 10-Q · filed 2021-07-23 | |||||||
| 2020-12-31 | $50.00K 10-K · filed 2021-03-31 | $13.12M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |